Type 2 diabetes increases the long ‐term risk of heart failure and mortality in patients with atrial fibrillation

ConclusionsAtrial fibrillation patients with T2DM have independently increased risk of new ‐onset/recurrent HF events, cardiovascular and all‐cause mortality, particularly when insulin‐treated. The prevailing phenotype of new‐onset HF was HFpEF; T2DM conferred higher risk of both HFpEF and HFmrEF/HFrEF.

Source: European Journal of Heart Failure - December 9, 2019 Category: Cardiology Authors: Marija Polovina, Lars H. Lund, Dijana Đikić, Ivana Petrović‐Đorđević, Gordana Krljanac, Ivan Milinković, Ivana Veljić, Massimo F. Piepoli, Giuseppe M.C. Rosano, Arsen D. Ristić, Milika Ašanin, Petar M. Seferović Tags: Research Article Source Type: research